Search Results - "D'Arminio Monforte, Antonella"
-
1
One‐year cognitive follow‐up of COVID‐19 hospitalized patients
Published in European journal of neurology (01-07-2022)“…Background and purpose Cognitive dysfunction has been observed following recovery from COVID‐19. To the best of our knowledge, however, no study has assessed…”
Get full text
Journal Article -
2
Long-Lasting Cognitive Abnormalities after COVID-19
Published in Brain sciences (13-02-2021)“…Considering the mechanisms capable of causing brain alterations in COVID-19, we aimed to study the occurrence of cognitive abnormalities in the months…”
Get full text
Journal Article -
3
Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A.: A modelling study
Published in PloS one (23-10-2017)“…Country-specific forecasts of the growing non-communicable disease (NCD) burden in ageing HIV-positive patients will be key to guide future HIV policies. We…”
Get full text
Journal Article -
4
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
Published in The Lancet (British edition) (19-07-2014)“…Summary Background With the advent of effective antiretroviral treatment, the life expectancy for people with HIV is now approaching that seen in the general…”
Get full text
Journal Article -
5
Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study
Published in The Journal of infectious diseases (01-02-2010)“…Background. The risk of myocardial infarction (MI) in patients with human immunodeficiency virus (HIV) infection has been assessed in 13 anti-HIV drugs in the…”
Get full text
Journal Article -
6
Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors
Published in Frontiers in immunology (10-06-2022)“…Two years into Coronavirus Disease 2019 (COVID-19) pandemic, a comprehensive characterization of the pathogenesis of severe and critical forms of COVID-19 is…”
Get full text
Journal Article -
7
Association between SARS-CoV-2 RNAemia and dysregulated immune response in acutely ill hospitalized COVID-19 patients
Published in Scientific reports (16-11-2022)“…Severe/critical COVID-19 is associated with immune dysregulation and plasmatic SARS-CoV-2 detection (i.e. RNAemia). We detailed the association of SARS-CoV-2…”
Get full text
Journal Article -
8
Impaired gut junctional complexes feature late-treated individuals with suboptimal CD4+ T-cell recovery upon virologically suppressive combination antiretroviral therapy
Published in AIDS (London) (24-04-2016)“…OBJECTIVE:HIV-infected individuals with incomplete CD4 T-cell recovery upon combination antiretroviral therapy (cART) display high levels of immune activation…”
Get full text
Journal Article -
9
Estimation of Improvements in Mortality in Spectrum Among Adults With HIV Receiving Antiretroviral Therapy in High-Income Countries
Published in Journal of acquired immune deficiency syndromes (1999) (01-01-2024)“…Mortality rates for people living with HIV (PLHIV) on antiretroviral therapy (ART) in high-income countries continue to decline. We compared mortality rates…”
Get full text
Journal Article -
10
Cost‐effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States
Published in AIDS (London) (01-03-2021)“…Background Expanding statin use may help to alleviate the excess burden of atherosclerotic cardiovascular disease in people living with HIV (PLHIV)…”
Get full text
Journal Article -
11
Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population
Published in PloS one (31-10-2017)“…to compare overall survival in HIV-associated lymphoma (HIV-L) and lymphoma raising in HIV-negative population (nHIV-L) and to identify predictors of increased…”
Get full text
Journal Article -
12
Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy
Published in HIV medicine (01-10-2024)“…Objectives The aim of this analysis was to investigate the impact of hepatitis B virus (HBV) coinfection on the risk of HIV viral rebound (VR) after achieving…”
Get full text
Journal Article -
13
The symptomatology of cerebrospinal fluid HIV RNA escape: a large case-series
Published in AIDS (London) (15-11-2021)“…Objective: To characterize the clinical, laboratory and radiological characteristics of persons with HIV (PWH) presenting with cerebrospinal fluid (CSF) HIV…”
Get full text
Journal Article -
14
Determinants of loss to care and risk of clinical progression in PLWH who are re-engaged in care after a temporary loss
Published in Scientific reports (05-05-2021)“…The risk of developing AIDS is elevated not only among those with a late HIV diagnosis but also among those lost to care (LTC). The aims were to address the…”
Get full text
Journal Article -
15
Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities: is it time to assess the definitions?
Published in AIDS (London) (15-03-2019)“…No consensus has been reached on how to define cerebrospinal fluid HIV-1 escape (CSF-E). We describe its prevalence in 1095 paired CSF-plasma HIV-RNA…”
Get full text
Journal Article -
16
Psychological outcomes after hospitalization for COVID-19: data from a multidisciplinary follow-up screening program for recovered patients
Published in Research in psychotherapy (Milano). (31-12-2020)“…Patients who are hospitalized for coronavirus disease 2019 (COVID-19) face an extremely stressful experience that might challenge their mental health. The…”
Get full text
Journal Article -
17
Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count
Published in AIDS (London) (17-07-2011)“…We investigated the significance of microbial translocation measured on average 3 years after HIV seroconversion in driving disease progression in HIV…”
Get full text
Journal Article -
18
Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study
Published in Viruses (19-07-2021)“…Objectives: HCV shows complex interactions with lipid metabolism. Our aim was to examine total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C)…”
Get full text
Journal Article -
19
Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHERE
Published in Clinical infectious diseases (15-07-2021)“…Abstract Background Using data from the COHERE collaboration, we investigated whether primary prophylaxis for pneumocystis pneumonia (PcP) might be withheld in…”
Get full text
Journal Article -
20
Influence of efavirenz and 8‐hydroxy‐efavirenz plasma levels on cognition and central nervous system side effects
Published in HIV medicine (01-04-2024)“…Objectives To investigate whether efavirenz (EFV) or 8‐hydroxy‐EFV (8‐OH‐EFV) plasma levels are associated with neurocognitive impairment and central nervous…”
Get full text
Journal Article